• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可生物降解支架联合碱性成纤维细胞生长因子局部控释及胶原包裹用于前交叉韧带再生

Regeneration of anterior cruciate ligament by biodegradable scaffold combined with local controlled release of basic fibroblast growth factor and collagen wrapping.

作者信息

Kimura Yuta, Hokugo Akishige, Takamoto Tomoaki, Tabata Yasuhiko, Kurosawa Hisashi

机构信息

Department of Biomaterials, Field of Tissue Engineering, Institute for Frontier Medical Sciences, Kyoto University, Kyoto, Japan.

出版信息

Tissue Eng Part C Methods. 2008 Mar;14(1):47-57. doi: 10.1089/tec.2007.0286.

DOI:10.1089/tec.2007.0286
PMID:18454645
Abstract

The objective of this study was to increase the therapeutic efficacy of anterior cruciate ligament (ACL) surgery using an artificial ligament material developed through a combination of tissue engineering technologies. A poly-L-lactic acid (PLLA) scaffold of plain-woven braid was incorporated with a gelatin hydrogel for controlled release of basic fibroblast growth factor (bFGF) and wrapped with a collagen membrane to allow space for ligament regeneration. For the ACL reconstruction surgery, the PLLA braid scaffold combined with the gelatin hydrogel incorporating bFGF and the collagen wrapping was applied to a tunnel prepared in the femur and tibia of rabbits. The hydrogel was placed in the bone, whereas the portion of the braid inside the joint cavity was wrapped with the membrane. As controls, the PLLA scaffold was applied with the hydrogel or the membrane, or without either material. Bone regeneration in the tunnel and ACL tissue regeneration in the joint cavity were histologically evaluated, and the mechanical strength and collagen content of the regenerated ACL were assessed. When the PLLA scaffold was integrated with both the hydrogel and the membrane, bone and ACL tissues were regenerated in the corresponding sites, in marked contrast to the control groups. Combination of bFGF-controlled release resulted in enhanced mechanical strength of the regenerated ACL tissue. In the joint cavity, it is possible that the local bFGF release inside the membrane enhanced the cell migration and collagen production, and that the surrounding PLLA scaffold results in the biological regeneration of ligament-like tissue. Additionally, significant bone regeneration around the scaffold was observed in the bone tunnel. It is therefore possible that the local controlled release of bFGF near the PLLA braid induced both osseointegration and intrascaffold cell migration in the bone tunnel and joint cavity, respectively, resulting in an overall increase in the mechanical strength of the regenerated ACL.

摘要

本研究的目的是通过结合组织工程技术开发的人工韧带材料来提高前交叉韧带(ACL)手术的治疗效果。将平纹编织的聚-L-乳酸(PLLA)支架与明胶水凝胶结合,用于碱性成纤维细胞生长因子(bFGF)的控释,并包裹胶原膜以留出韧带再生的空间。对于ACL重建手术,将结合了含bFGF的明胶水凝胶和胶原包裹的PLLA编织支架应用于兔股骨和胫骨制备的隧道中。水凝胶置于骨内,而关节腔内编织物的部分则用膜包裹。作为对照,PLLA支架单独应用水凝胶或膜,或不应用任何一种材料。对隧道内的骨再生和关节腔内的ACL组织再生进行组织学评估,并评估再生ACL的机械强度和胶原含量。当PLLA支架与水凝胶和膜两者结合时,相应部位再生出骨和ACL组织,这与对照组形成明显对比。bFGF控释的联合应用导致再生ACL组织的机械强度增强。在关节腔内,膜内局部bFGF释放可能增强了细胞迁移和胶原产生,并且周围的PLLA支架导致韧带样组织的生物再生。此外,在骨隧道中观察到支架周围有明显的骨再生。因此,PLLA编织物附近bFGF的局部控释可能分别在骨隧道和关节腔内诱导了骨整合和支架内细胞迁移,从而导致再生ACL的机械强度总体增加。

相似文献

1
Regeneration of anterior cruciate ligament by biodegradable scaffold combined with local controlled release of basic fibroblast growth factor and collagen wrapping.可生物降解支架联合碱性成纤维细胞生长因子局部控释及胶原包裹用于前交叉韧带再生
Tissue Eng Part C Methods. 2008 Mar;14(1):47-57. doi: 10.1089/tec.2007.0286.
2
Anterior cruciate ligament regeneration using braided biodegradable scaffolds: in vitro optimization studies.使用编织型可生物降解支架进行前交叉韧带再生:体外优化研究
Biomaterials. 2005 Aug;26(23):4805-16. doi: 10.1016/j.biomaterials.2004.11.050. Epub 2005 Jan 13.
3
Long-term effects of knitted silk-collagen sponge scaffold on anterior cruciate ligament reconstruction and osteoarthritis prevention. knitted 丝胶原蛋白海绵支架对前交叉韧带重建和预防骨关节炎的长期影响。
Biomaterials. 2014 Sep;35(28):8154-63. doi: 10.1016/j.biomaterials.2014.06.019. Epub 2014 Jun 25.
4
Ectopic tissue engineered ligament with silk collagen scaffold for ACL regeneration: A preliminary study.用于前交叉韧带再生的丝胶原支架异位组织工程韧带:一项初步研究。
Acta Biomater. 2017 Apr 15;53:307-317. doi: 10.1016/j.actbio.2017.02.027. Epub 2017 Feb 16.
5
Exogenous stromal derived factor-1 releasing silk scaffold combined with intra-articular injection of progenitor cells promotes bone-ligament-bone regeneration.外源性基质衍生因子 1 释放丝素支架结合关节内注射祖细胞促进骨-韧带-骨再生。
Acta Biomater. 2018 Apr 15;71:168-183. doi: 10.1016/j.actbio.2018.02.019. Epub 2018 Mar 7.
6
Evaluation of a hydrogel-fiber composite for ACL tissue engineering.水凝胶纤维复合材料在 ACL 组织工程中的评价。
J Biomech. 2011 Feb 24;44(4):694-9. doi: 10.1016/j.jbiomech.2010.10.043. Epub 2010 Dec 15.
7
Preparation of collagen/gelatin sponge scaffold for sustained release of bFGF.用于碱性成纤维细胞生长因子持续释放的胶原/明胶海绵支架的制备
Tissue Eng Part A. 2008 Oct;14(10):1629-38. doi: 10.1089/ten.tea.2007.0215.
8
Anterior cruciate ligament constructs fabricated from human mesenchymal stem cells in a collagen type I hydrogel.由人间充质干细胞在I型胶原蛋白水凝胶中构建的前交叉韧带。
Cytotherapy. 2005;7(5):447-55. doi: 10.1080/14653240500319093.
9
[A PRELIMINARY STUDY ON SMALL INTESTINAL SUBMUCOSA-SILK COMPOSITE SCAFFOLD TO RECONSTRUCT ANTERIOR CRUCIATE LIGAMENT].小肠黏膜下层-丝素复合支架重建前交叉韧带的初步研究
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2015 Dec;29(12):1534-40.
10
A Novel Silk Fiber-Based Scaffold for Regeneration of the Anterior Cruciate Ligament: Histological Results From a Study in Sheep.一种用于前交叉韧带再生的新型丝纤维基支架:绵羊研究的组织学结果
Am J Sports Med. 2016 Jun;44(6):1547-57. doi: 10.1177/0363546516631954. Epub 2016 Mar 8.

引用本文的文献

1
Intermittent cyclic stretch of engineered ligaments drives hierarchical collagen fiber maturation in a dose- and organizational-dependent manner.工程化韧带的间歇循环拉伸以剂量和组织依赖性的方式驱动分层胶原纤维成熟。
Acta Biomater. 2024 Sep 1;185:296-311. doi: 10.1016/j.actbio.2024.07.025. Epub 2024 Jul 16.
2
Anatomical Tissue Engineering of the Anterior Cruciate Ligament Entheses.前交叉韧带止点的解剖组织工程学
Int J Mol Sci. 2023 Jun 5;24(11):9745. doi: 10.3390/ijms24119745.
3
Research progress of functional motifs based on growth factors in cartilage tissue engineering: A review.
基于生长因子的软骨组织工程功能基序研究进展:综述
Front Bioeng Biotechnol. 2023 Feb 7;11:1127949. doi: 10.3389/fbioe.2023.1127949. eCollection 2023.
4
Natural, synthetic and commercially-available biopolymers used to regenerate tendons and ligaments.用于再生肌腱和韧带的天然、合成及市售生物聚合物。
Bioact Mater. 2022 Apr 13;19:179-197. doi: 10.1016/j.bioactmat.2022.04.003. eCollection 2023 Jan.
5
Tackling the Challenges of Graft Healing After Anterior Cruciate Ligament Reconstruction-Thinking From the Endpoint.从终点思考应对前交叉韧带重建术后移植物愈合的挑战
Front Bioeng Biotechnol. 2021 Dec 22;9:756930. doi: 10.3389/fbioe.2021.756930. eCollection 2021.
6
[Research progress of interfacial tissue engineering in rotator cuff repair].[肩袖修复中界面组织工程的研究进展]
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2021 Oct 15;35(10):1341-1351. doi: 10.7507/1002-1892.202104064.
7
Bioinspired Scaffold Designs for Regenerating Musculoskeletal Tissue Interfaces.用于再生肌肉骨骼组织界面的仿生支架设计
Regen Eng Transl Med. 2020 Dec;6(4):451-483. doi: 10.1007/s40883-019-00132-3. Epub 2019 Dec 17.
8
Biodegradable polymer nanocomposites for ligament/tendon tissue engineering.用于韧带/肌腱组织工程的可生物降解聚合物纳米复合材料。
J Nanobiotechnology. 2020 Jan 30;18(1):23. doi: 10.1186/s12951-019-0556-1.
9
Dual Crosslinked Methacrylated Alginate Hydrogel Micron Fibers and Tissue Constructs for Cell Biology.双重交联甲基丙烯酰化海藻酸钠水凝胶微米纤维和组织构建物用于细胞生物学。
Mar Drugs. 2019 Sep 28;17(10):557. doi: 10.3390/md17100557.
10
Enhancement of in vitro proliferation and bioactivity of human anterior cruciate ligament fibroblasts using an in situ tissue isolation method and basic fibroblast growth factor culture conditions: A pilot analysis.使用原位组织分离方法和碱性成纤维细胞生长因子培养条件增强人前交叉韧带成纤维细胞的体外增殖和生物活性:一项初步分析。
Medicine (Baltimore). 2019 May;98(22):e15907. doi: 10.1097/MD.0000000000015907.